Who We Are?


Principal & Founder

Dr. Neeraj Vij is a President & CEO of PRECISION THERANOSTICS & VIJ BIOTECH. He is a prominent scientist with expertise in respiratory medicine, and drug and medical device development. Dr. Vij’s laboratory over the years have been involved in development of novel prognosis-based intervention strategies, leading to the foundation of PTNx for bench to bedside translation for serving the needs of patients suffering from chronic or fatal conditions.

Dr. Vij received his PhD in Biotechnology from Indian Institute of Technology in 2001, and was also a recipient of international fellowship at Institute of Genetics, Biological Research Center (Centre of Excellence of the European Union), Hungary in same year. He subsequently completed his postdoctoral research at University of Heidelberg, Germany and Johns Hopkins University School of Medicine. He was Assistant Professor at the Department of Pediatrics, Pulmonary Medicine and Institutes of NanoBiotechnology and Global Health, JHU before moving to CMU to help establish a new medical school as an Associate Professor. He continues to serve as Adjunct Faculty at Johns Hopkins University School of Medicine.

Dr. Vij serves on the Editorial Boards of several high impact journals and has been invited to help organize several conferences and seminars. He is also frequently invited to serve as a reviewer for various Journals and grant review study sections. He is a Life Member of American Society for Nano Medicine (ASNM) and several other international scientific societies. He is a recipient of several research awards, grants (NIH and foundation) and recognition for his scientific contributions. He has also been involved in training and education of students and research/clinical fellows in various capacities leading to placements at top-tier universities, medical schools or industries.

Contact Dr. Vij via email nvij@precisiontheranostic.com or call @240-623-0757

Medical Advisory Board

Dr. Erich Gulbins obtained his medical and doctoral degrees from the University of Heidelberg, Germany, followed by postdoctoral fellowship at La Jolla Institute of Allergy and Immunology. Dr. Gulbins is a Professor and Chair of Institute of Molecular Biology, and Medical Faculty at University of Duisburg-Essen, Germany. He is also an Adjunct Professor at Department of Surgery and College of Medicine, University of Cincinnati. He is an internationally recognized expert on the role of sphingolipids metabolism in infection, airway diseases and tumor progression. His research focuses on host-pathogen interaction and immune responses in airway diseases such a Cystic Fibrosis and tumor-host interactions.

Dr. Gulbins has authored more than 240 scientific publications and received various academic awards and research grants. He is a founder and Chief Scientific Officer of Harbins Ruhr Bioscience, Inc. Dr. Gulbin’s insights in pathogenesis of airway diseases and molecular mechanisms of disease progression are valuable for PTNx clinical development pipeline.

Dr. Clemens Esche obtained his medical degree from the University of Cologne, Germany, prior to completing a residency at the University of Düsseldorf, Germany. Dr. Esche subsequently performed research and was an Assistant Professor at the University of Pittsburgh, the Mayo Clinic and at Johns Hopkins University. Dr. Esche has authored more than 70 scientific publications and received more than 10 academic awards for his research.

He was recognized with the Patient’s Choice Award in 2013 and 2018, and the On-Time Doctor Award in 2015. Compassionate Doctor Recognition has been granted in 2018. This honor is based on a physician’s overall and bedside manner scores. Dr. Esche’s academic and clinical insight compliments the PTNx expertise.


Slogan / Motto

Innovative prognosis based early intervention is a key to improving survival and cure chronic or fatal diseases.

Mission Statement

PRECISION THERANOSTICS is focused on development of novel diagnostics, therapeutics and prognosis based therapies for improving survival and finding cure for chronic repisratory diseases and age-related disorders.